PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsRVL Pharmaceuticals
RVL Pharmaceuticals(RVLP)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
UpneeqOxymetazoline2020-07-082024-2039
Sinusitis
,
Conjunctivitis
,
Rhinitis
,
Common cold
,
Pain
DonepezilDonepezil2016-01-262025-2038
Alzheimer disease
HydromorphoneHydromorphone2016-07-072032-2034
Postoperative pain
,
Cough
NifedipineNifedipine2005-11-21
Hypertension,
Stable angina,
Variant angina pectoris
OxybutyninOxybutynin2009-02-042029-2031
Neurogenic urinary bladder,
Urge urinary incontinence,
Urinary incontinence,
Dysuria
RelexxiiMethylphenidate2022-06-232024-2038
Narcolepsy,
Attention deficit disorder with hyperactivity,
Depressive disorder
MethylphenidateMethylphenidate2017-07-282024-2038
Narcolepsy,
Attention deficit disorder with hyperactivity,
Depressive disorder
VenlafaxineVenlafaxine2008-05-202023-2028
Pain,
Chronic fatigue syndrome,
Attention deficit disorder with hyperactivity,
Obsessive-compulsive disorder,
Depressive disorder,
Autistic disorder
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Oxymetazoline
blepharoptosis
Arbaclofen
multiple sclerosis
,
muscle spasticity
,
sclerosis
Alfacalcidol
blepharoptosis
Cycloplegics
blepharoptosis
Mydriatics
blepharoptosis
RVL
blepharoptosis
Ipx066
parkinson disease
Mydfrin
blepharoptosis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use